Literature DB >> 31964455

Left ventricular dysfunction in Duchenne muscular dystrophy.

Katherine A James1, Jane Gralla2, Leslie A Ridall3, ThuyQuynh N Do4, Angela S Czaja3, Peter M Mourani3, Emma Ciafaloni5, Christopher Cunniff6, Jennifer Donnelly3, Joyce Oleszek3, Shree Pandya5, Elinora Price6, Michele L Yang3, Scott R Auerbach3.   

Abstract

BACKGROUND: Duchenne muscular dystrophy is associated with progressive cardiorespiratory failure, including left ventricular dysfunction. METHODS AND
RESULTS: Males with probable or definite diagnosis of Duchenne muscular dystrophy, diagnosed between 1 January, 1982 and 31 December, 2011, were identified from the Muscular Dystrophy Surveillance Tracking and Research Network database. Two non-mutually exclusive groups were created: patients with ≥2 echocardiograms and non-invasive positive pressure ventilation-compliant patients with ≥1 recorded ejection fraction. Quantitative left ventricular dysfunction was defined as an ejection fraction <55%. Qualitative dysfunction was defined as mild, moderate, or severe. Progression of quantitative left ventricular dysfunction was modelled as a continuous time-varying outcome. Change in qualitative left ventricle function was assessed by the percentage of patients within each category at each age. Forty-one percent (n = 403) had ≥2 ejection fractions containing 998 qualitative assessments with a mean age at first echo of 10.8 ± 4.6 years, with an average first ejection fraction of 63.1 ± 12.6%. Mean age at first echo with an ejection fraction <55 was 15.2 ± 3.9 years. Thirty-five percent (140/403) were non-invasive positive pressure ventilation-compliant and had ejection fraction information. The estimated rate of decline in ejection fraction from first ejection fraction was 1.6% per year and initiation of non-invasive positive pressure ventilation did not change this rate.
CONCLUSIONS: In our cohort, we observed that left ventricle function in patients with Duchenne muscular dystrophy declined over time, independent of non-invasive positive pressure ventilation use. Future studies are needed to examine the impact of respiratory support on cardiac function.

Entities:  

Keywords:  Duchenne muscular dystrophy; left ventricular dysfunction; non-invasive positive pressure ventilation

Mesh:

Substances:

Year:  2020        PMID: 31964455      PMCID: PMC8941672          DOI: 10.1017/S1047951119002610

Source DB:  PubMed          Journal:  Cardiol Young        ISSN: 1047-9511            Impact factor:   1.093


  33 in total

Review 1.  Corticosteroids in Duchenne muscular dystrophy: a reappraisal.

Authors:  Brenda L Y Wong; Caroline Christopher
Journal:  J Child Neurol       Date:  2002-03       Impact factor: 1.987

2.  Cardiac and pulmonary function variability in Duchenne/Becker muscular dystrophy: an initial report.

Authors:  David J Birnkrant; Mahi Lakshmi Ashwath; Garey H Noritz; Michelle C Merrill; Tushar A Shah; Carol A Crowe; Robert C Bahler
Journal:  J Child Neurol       Date:  2010-05-25       Impact factor: 1.987

Review 3.  A primer in longitudinal data analysis.

Authors:  Garrett M Fitzmaurice; Caitlin Ravichandran
Journal:  Circulation       Date:  2008-11-04       Impact factor: 29.690

4.  Contemporary cardiac issues in Duchenne muscular dystrophy. Working Group of the National Heart, Lung, and Blood Institute in collaboration with Parent Project Muscular Dystrophy.

Authors:  Elizabeth M McNally; Jonathan R Kaltman; D Woodrow Benson; Charles E Canter; Linda H Cripe; Dongsheng Duan; Jonathan D Finder; William J Groh; Eric P Hoffman; Daniel P Judge; Naomi Kertesz; Kathi Kinnett; Roxanne Kirsch; Joseph M Metzger; Gail D Pearson; Jill A Rafael-Fortney; Subha V Raman; Christopher F Spurney; Shari L Targum; Kathryn R Wagner; Larry W Markham
Journal:  Circulation       Date:  2015-05-05       Impact factor: 29.690

5.  Muscular Dystrophy Surveillance Tracking and Research Network (MD STARnet): case definition in surveillance for childhood-onset Duchenne/Becker muscular dystrophy.

Authors:  Katherine D Mathews; Chris Cunniff; Jiji R Kantamneni; Emma Ciafaloni; Timothy Miller; Dennis Matthews; Valerie Cwik; Charlotte Druschel; Lisa Miller; F John Meaney; John Sladky; Paul A Romitti
Journal:  J Child Neurol       Date:  2010-09       Impact factor: 1.987

6.  Visually estimated left ventricular ejection fraction by echocardiography is closely correlated with formal quantitative methods.

Authors:  Petri Gudmundsson; Erik Rydberg; Reidar Winter; Ronnie Willenheimer
Journal:  Int J Cardiol       Date:  2005-05-25       Impact factor: 4.164

7.  Dystrophin genotype-cardiac phenotype correlations in Duchenne and Becker muscular dystrophies using cardiac magnetic resonance imaging.

Authors:  Animesh Tandon; John L Jefferies; Chet R Villa; Kan N Hor; Brenda L Wong; Stephanie M Ware; Zhiqian Gao; Jeffrey A Towbin; Wojciech Mazur; Robert J Fleck; Joshua J Sticka; D Woodrow Benson; Michael D Taylor
Journal:  Am J Cardiol       Date:  2015-01-15       Impact factor: 2.778

Review 8.  Cardiopulmonary support in duchenne muscular dystrophy.

Authors:  Josef Finsterer
Journal:  Lung       Date:  2006 Jul-Aug       Impact factor: 2.584

9.  Dystrophin protects the sarcolemma from stresses developed during muscle contraction.

Authors:  B J Petrof; J B Shrager; H H Stedman; A M Kelly; H L Sweeney
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

10.  Effect of non-invasive ventilation on respiratory muscle loading and endurance in patients with Duchenne muscular dystrophy.

Authors:  M Toussaint; P Soudon; W Kinnear
Journal:  Thorax       Date:  2007-12-05       Impact factor: 9.139

View more
  3 in total

1.  Direct costs of adhering to selected Duchenne muscular dystrophy Care Considerations: Estimates from a midwestern state.

Authors:  Kristin M Conway; Scott D Grosse; Lijing Ouyang; Natalie Street; Paul A Romitti
Journal:  Muscle Nerve       Date:  2022-02-09       Impact factor: 3.852

Review 2.  The role of the dystrophin glycoprotein complex in muscle cell mechanotransduction.

Authors:  Darren Graham Samuel Wilson; Andrew Tinker; Thomas Iskratsch
Journal:  Commun Biol       Date:  2022-09-27

3.  Cardiovascular phenotype of the Dmdmdx rat - a suitable animal model for Duchenne muscular dystrophy.

Authors:  Petra Lujza Szabó; Janine Ebner; Xaver Koenig; Ouafa Hamza; Simon Watzinger; Sandra Trojanek; Dietmar Abraham; Hannes Todt; Helmut Kubista; Klaus Schicker; Séverine Remy; Ignacio Anegon; Attila Kiss; Bruno K Podesser; Karlheinz Hilber
Journal:  Dis Model Mech       Date:  2021-02-22       Impact factor: 5.732

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.